N/A N=3,632 Epidemiological Study of the COVID-2019 in Participating Organizations.
Covid19
Primary: The Incidence of COVID-2019 Cases. — 259.95 COVID-2019 cases per 1000 person
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=21,240 A Safety Study For Prevenar 13 Among Chinese Children
Seizures · Urticaria and Angioedema · Apnea
Primary: Incidence Rate (Per 1000 Person Days) of All Seizures Through 0 to 3 Days After Dose 1 — NA; NA Events per 1000 person-days
N/A N=974 Reduction of Exposure, Inflammation, and Oxidative Stress Following at Least 2 Years of Switching to THS Use Compared to Cigarette Smoking
Inflammation · Oxidative Stress · Smoking
Primary: Carboxyhemoglobin (COHb) in Blood — 3.07; 1.52; 1.49 % of CO saturated hemoglobin — p=<0.001
N/A N=170 Cross-sectional Evaluation of the Subjective Performance and Satisfaction With Ponto Sound Processors
Hearing Loss · Hearing Loss, Conductive · Hearing Loss, Unilateral
Primary: Overall IOI-HA Score — 3.98; 3.96; 3.86; 4.02 score on a scale
N/A N=162 KBTH-GIRHL Healthy Birth Weight Study: A Cross-Section
Infant, Small for Gestational Age · Infant, Low Birth Weight · Pregnancy
Primary: Birth Weight of Baby — 3033 grams
N/A N=61 A Cross-sectional Study to Measure Cough in Severe Asthma
Asthma · Cough
Primary: Cough Frequency Measurement — 6.6; 2.7; 2.5; 12.7 coughs per hour over a 24 hour monitorin
N/A N=57 Screening for HPV and Cervical Cancer in Young Women With Perinatally Acquired HIV
HIV Infections · Human Papillomavirus Infection · Cervical Cancer
Primary: Prevalence of Abnormal Cervical Cytology — 12 Participants
N/A N=6,802 Study to Assess Oropharyngeal Carriage of N. Meningitidis in South Australian School Leavers
Neisseria Meningitidis
Primary: Estimate the Difference in Carriage Prevalence of Disease Associated Genogroups of N. Meningitidis (A, B, C, W, X, Y) Between School Leavers in 2018 (Year 12 in 2017)…
N/A N=1,105 Female Patient Preferences Regarding Physician Gender
Female Patient Preference
Primary: Proportion of Female Respondents Having Their Preferences Based on Physician Gender for the OB/GYN Care — 667; 87; 261 Participants
N/A N=843 Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure
Hypothyroidism
Primary: Number of Pediatric Patients With Detected Hypothyroidism After Iodinated Contrast Exposure in a Routine Clinical Practice Setting — 11 Participants
N/A N=17,464 A Study Based on Health Insurance Data About the Treatment of Patients Who Have Been Newly Diagnosed With Chronic Obstructive Pulmonary Disease (COPD)
Pulmonary Disease, Chronic Obstructive
Primary: Description of Real-life Drug Treatment After Incident Diagnosis - COPD-12 Sample — 35.6; 30.3; 29.1; 25.0 Percentage of Patients
N/A N=327 Morbidity in Newly Diagnosed type2 Diabetes in Adults
Type2 Diabetes Mellitus · Complications
Primary: Number and Prevalence of Patients With Diabetic Retinopathy — 9; 18 Participants — p=0.706
N/A N=3,830 Seroepidemiological Study of Pertussis and Other Infectious Diseases
Pertussis Infection
Primary: IgG — 1.254; 1.258 EU/mL(log transformed)
N/A N=179 Epidemiologic Analysis of Change in Eyelash Characteristics With Age in Healthy Women
Health
Primary: Eyelash Length as Measured by Digital Image Analysis (DIA) — 7.33 Millimeters (mm)
N/A N=73 Descriptive Observational Study ALK-2016-CPHG
NSCLC · Crizotinib · ALK Gene Rearrangement or ROS1 Gene Rearrangement
Primary: Age: Line of Treatment — 62.3; 63.1; 56.5; 64.3 Years
N/A N=127 Feasibility Study on the Model School Pediatric Health Initiative Pilot Project
School Board Health Centers
Primary: Number of Enrolled Participants Who Attended SBHC — 127; 252 participants
N/A N=35 Intervention Study on the Health Impact of Air Filters in Chinese Adults
Inflammation · Coagulation · Blood Pressure
Primary: Circulating Biomarkers — 926.3; 913.1; 1122.2; 1108.2 ng/ml
N/A N=48 Cohort Isolation and Cross-infection in Bronchiolitis
Bronchiolitis
Primary: Duration of Hospital Stay — 3.9; 2.1 days
N/A N=6,617 Observational Data Analysis in EuroSIDA (MK-0518-058)
HIV-1 Infections
Primary: Incidence of Malignancy — 1.29; 1.17; 0.81 Events per 100 person-years of follow-up
N/A N=300 A COHORT STUDY TO EVALUATE IMMUNOGENICITY FOR CHINESE CHILDREN AT THE TIME OF CLINICAL PNEUMONIA DIAGNOSIS
Immunogenicity, Vaccine
Primary: Geometric Mean Concentrations (GMCs) of Pneumococcal Immunoglobulin G (IgG) by Cohort — 1.55; 0.12; 0.42; 0.07 microgram per milliliter (µg/mL)
N/A N=129 Multicenter Descriptive Study of the Patient Clinical Profile That Begins With Disseminated Her 2 + Breast Cancer or Develops a Metastasis After or During the Adjuvant Therapy
Disseminated HER2+ Breast Cancer
Primary: The Patient Clinical Profile (General Clinical Data and Breast Cancer Characteristics) — 63.5; 48.8; 84.1; 41.1 percentage of participants
N/A N=170 Stressor-evoked Brain and Cardiovascular Responses to Acute Psychological Stress
Acute Psychological Stress
Primary: Stressor-evoked Oxygen Consumption in mL/(kg·Min) (Stress - Baseline) — 0.265; 0.287 mL/(kg·min)
N/A N=120 College Student Stress: Transitions Over Time
Depressive Symptoms
Primary: Percentage of Eligible Participants Who Agreed to Participate in the Trial — 120 Participants
N/A N=6,350 Universal HIV Screening and Targeted HCV Screening in Emergency Department
Hepatitis C · Hiv
Primary: Prevalence — 78; 118; 2; 9 Participants
N/A N=162 Tumor: Breast Ratio Study
Breast Cancer · LCIS · DCIS
Primary: Quality of Life as Measured by the Breast Q — 61.9; 57.6; 74.2; 64.2 score on a scale
N/A N=86 A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects
HIV · Hepatitis C
Primary: Reactive Hyperemia Index (RHI) by Peripheral Arterial Tonometry (PAT) — 1.98; 2.15 ratio
N/A N=684,815 Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)
Esophageal Cancer · Squamous Cell Carcinoma · Adenocarcinoma
Primary: Percentage of Participants With Exposure to Study Drugs (Case-Cohort Analysis) — 4.6; 2.7; 3.7; 2.1 Percentage of participants
N/A N=49 A Retrospective Study of Real World Treatment Outcomes of Patients With Chronic Hepatitis C
Hepatitis C, Chronic
Primary: Sustained Virological Response (SVR): Percentage of Participants Who Were HCV Seronegative at 6 Months After Completing Therapy — 59.5; 58.3 percentage of participants
N/A N=369 Comparison of eBX and Mohs Surgery for Treatment of Early-stage Non-melanoma Skin Cancer a Matched Pair Cohort Study.
Nonmelanoma Skin Cancer
Primary: Absence of Local Recurrence at Treatment Site(s) Greater or Equal to 3 Years Follow-up — 188; 181; 187; 181 participants
N/A N=500 This Study Observes the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Elderly Patients With a Heart Rhythm Disorder in Spain
Atrial Fibrillation
Primary: Type of Current Non-vitamin K Antagonist Oral Anticoagulant (NOAC) and Current NOAC Dose According to Sex — 115; 77; 30; 46 Participants